Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type 1 selected

Type

Guidance programme

HealthTech approach

HealthTech approach

Area of interest

Showing 701 to 710 of 2054

TitleReference numberPublishedLast updated
Pembrolizumab for adjuvant treatment of completely resected stage 3 melanomaTA766
Ponesimod for treating relapsing–remitting multiple sclerosisTA767
Upadacitinib for treating active psoriatic arthritis after inadequate response to DMARDsTA768
Daratumumab in combination for untreated multiple myeloma when a stem cell transplant is suitableTA763
Fremanezumab for preventing migraineTA764
Venetoclax with azacitidine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitableTA765
Sedaconda ACD-S for sedation with volatile anaesthetics in intensive careHTG607
Glaucoma: diagnosis and managementNG81
Rehabilitation after traumatic injuryNG211
Cabotegravir with rilpivirine for treating HIV-1TA757

Results per page

  1. 10
  2. 25
  3. 50
  4. All